Berg Health

BERG is a clinical-stage, AI-powered biotech company that utilizes its proprietary platform, Interrogative Biology®, to map diseases and revolutionize the treatment of cancer, neurological disorders, and rare diseases. By adopting the Back to Biology™ approach, BERG is able to identify key biomarkers that can accelerate the discovery and development of treatments targeting the most promising therapeutic targets and pathways.